Medical / Pharmaceuticals
Releases published in the last 30 days. 
Page 1 of 2
- Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease
- 4/1/2026 12:31:42 PM
- Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease • Rezurock is now approved in the EU for adults and children aged 12 years and older with chronic GVHD, providing a new medicine for patients with limited treatment options The European Commission has granted a conditional marketing authorisation for Rezurock (belumosudil) for the …
- Efzimfotase alfa demonstrated positive results from global Phase III clinical programme in hypophosphatasia
- 4/1/2026 11:16:38 AM
- This announcement contains inside information CHESTNUT randomised, open-label, active-controlled trial demonstrated safety and tolerability of efzimfotase alfa in paediatric patients previously treated with Strensiq with maintenance of therapeutic benefit MULBERRY randomised, placebo-controlled trial showed efzimfotase alfa demonstrated statistically significant and …
- INLEXZO™ (gemcitabine intravesical system) Assigned Permanent Billing Code, Supporting Access for Patients with Certain Bladder Cancers
- 4/1/2026 10:56:01 AM
- Johnson & Johnson (NYSE:JNJ) today announced the permanent Healthcare Common Procedure Coding System (HCPCS) J-code for INLEXZO™ (gemcitabine intravesical system) is now in effect.
- THMT Releases 2025 Research Compendium Featuring Global Advances in Telehealth, AI, and Digital Medicine
- 3/31/2026 8:00:00 AM
- Telehealth and Medicine Today (THMT) today announced the release of its 2025 Open Access Research Compendium, featuring a comprehensive collection of peer reviewed articles alongside its expanding archive of real world research shaping telehealth, artificial intelligence (AI), and digital medicine worldwide.
- Jimini Health Raises $17M as Behavioral Health Systems Face Growing Pressure to Manage Patient AI Use with Clinical-Grade Infrastructure
- 3/31/2026 6:00:00 AM
- Jimini Health today announced $17 million in seed funding from M13, Town Hall Ventures, LionBird, Zetta Venture Partners, and OneMind, bringing total funding to more than $25 million.
- MENU - ORDER AI Becomes #1 App for GLP-1 Meal Searches on the Apple App Store in the United States
- 3/30/2026 2:28:11 PM
- MENU - ORDER AI, the AI-powered dining companion helping users choose high-protein, GLP-1 friendly meals in seconds, announced today that it has become the #1 app searched for GLP-1 meal guidance on the Apple App Store in the United States.
- Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma
- 3/30/2026 9:51:58 AM
- The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Sarclisa (isatuximab) subcutaneous (SC) in combination with approved standard-of-care regimens for the treatment of patients with multiple myeloma (MM) across all currently approved indications for Sarclisa intravenous (IV) …
- BHTY Unveils 2025 Research Compendium Advancing Global Leadership in Blockchain, AI, and Digital Health
- 3/30/2026 8:00:00 AM
- Blockchain in Healthcare Today (BHTY) today announced the release of its 2025 Research Compendium, featuring all original research articles published this year alongside the complete archive of peer reviewed research since the journal’s launch.
- CMS launches model to improve care coordination for children and families
- 3/27/2026 10:01:01 AM
- The American Medical Association (AMA) welcomed a newly announced care model from the Centers for Medicare & Medicaid Services (CMS) designed to help Medicaid families better navigate and coordinate their health care.
- Activating Your Brain While Sitting Helps Reduce Dementia Risk
- 3/26/2026 11:08:15 AM
- New research distinguishing between passive and mentally active sitting in association with dementia has found that adults who engaged in extended durations of mentally passive sedentary behaviors had a higher risk of dementia.
- AMA launches nutrition education initiative
- 3/25/2026 10:52:11 AM
- The American Medical Association (AMA) is launching a nutrition education initiative to equip physicians and medical students with practical, evidence-based knowledge and tools to help patients live healthier lives.
- Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid
- 3/24/2026 1:40:24 PM
- • Approval in moderate-to-severe patients was based on pivotal study results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo • BP is a chronic, relapsing skin disease with underlying type 2 inflammation characterized by intense itch alongside painful blisters and other lesions • BP is the …
- Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease
- 3/19/2026 12:40:05 PM
- The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to venglustat, a novel, investigational oral glucosylceramide synthase inhibitor (GCSi), for the treatment of neurological manifestations of type 3 Gaucher disease (GD3), a rare lysosomal storage disorder.
- FDA approval of ICOTYDE™ (icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide
- 3/19/2026 9:18:14 AM
- Johnson & Johnson introduces the first and only IL-23R targeted oral peptide that delivers complete skin clearance and favorable safety profile in a once-daily pill ICOTYDE offers an innovative new option for patients with moderate-to-severe plaque psoriasis to address patients cycling on topical therapies in need of systemic treatment Johnson & Johnson (NYSE: JNJ) …
- Elsevier expands article submission screening tool to strengthen research credibility
- 3/19/2026 8:50:11 AM
- Elsevier has expanded its Check Integrity screening tool across nearly 2,000 of its journals to help identify potential ethical issues in research papers before publication, following a successful pilot phase.
- Middle East regional conflict blocking lifesaving aid for over 400,000 children
- 3/19/2026 8:48:22 AM
- The conflict in the Middle East and wider region is obstructing key delivery routes for humanitarian supplies, delaying lifesaving medical shipments for at least 410,000 children in three countries, said Save the Children, warning the global impact will only grow.1 The escalating conflict is having dire ripple effects on global aid supplies due to disruptions to key …
- Future Family Partners with Kindbody to Expand Access to Fertility Care Through Innovative Financing Solutions
- 3/18/2026 8:00:00 AM
- Future Family, the only financing platform built exclusively for fertility patients, today announced a partnership with Kindbody, a leading fertility and family-building benefits provider and fertility care delivery platform.
- L’Oréal and Nvidia to accelerate beauty discovery powered by predictive AI science
- 3/18/2026 3:17:45 AM
- L’Oréal announced the expansion of its AI partnership with NVIDIA, aimed at accelerating and re-defining beauty innovation through AI-driven computational chemistry.
- Recent Open Access Research on Telemedicine Adoption, AI in Healthcare, Digital Health Innovation, and Cybersecurity
- 3/17/2026 8:00:00 AM
- The current issue of Telehealth and Medicine Today ( THMT ) highlights how telemedicine, artificial intelligence, and digital health technologies are moving from experimentation to real world implementation across healthcare systems globally.
- MedPAC to Congress: Increase Medicare payments
- 3/16/2026 11:32:41 AM
- The Medicare Payment Advisory Commission (MedPAC) recommended (PDF) that Congress increase the payment update for physicians caring for Medicare patients in 2027, reinforcing the urgent need to stabilize Medicare physician payment and protect patient access to care.